Live Breaking News & Updates on Lowe meisel

Stay updated with breaking news from Lowe meisel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Real-World Patient Characteristics and Treatment Patterns Associated With Tucatinib Therapy in Patients With HER2+ Metastatic Breast Cancer

Jane Lowe Meisel, MD, presents data from a retrospective study investigating patient characteristics, treatment patterns, and clinical outcomes for tucatinib-based treatment in the real-world setting both overall and following fam-trastuzumab deruxtecan (T-DXd). ....

Jane-lowe-meisel , Real-world-patient-characteristics , Patients-with , Metastatic-breast , Lowe-meisel , Tucatinib , Her2-metastatic-breast-cancer , Mbc , Tucatinib-based-treatment , Fam-trastuzumab-deruxtecan , T-dxd

Atlanta's Top Docs share their stories of unexpected, inspiring, and memorable cases

Atlanta's Top Docs share their stories of unexpected, inspiring, and memorable cases
atlantamagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from atlantamagazine.com Daily Mail and Mail on Sunday newspapers.

Mexico , New-york , United-states , Dekalb-medical-center , Georgia , Morehouse-school-of-medicine , Emory-university , Hall-county , Atlanta , Washington , Fort-benning , Spain

TROPiCS-02 Trial Sees Progression-Free Survival Edge for Trodelvy-Treated Advanced Breast Cancers

The antibody-drug conjugate stretched out time to progression in a Phase III trial of pretreated patients with advanced hormone receptor-positive, HER2-negative breast cancers. ....

California , United-states , Foster-city , San-francisco , American , Jane-lowe-meisel , Veronique-dieras , University-of-california , Eugene-marquis-center , American-society-of-clinical-oncology , Emory-university , Drug-administration